1. Pink Sheet

GSK Malaria Vaccine Gets Landmark Clearance For Use In Africa

WHO Recommendation Takes Account Of 2015 EMA Scientific Opinion

 
• By Ian Schofield

Mosquirix is set for much wider availability in sub-Saharan Africa thanks to positive results from a pilot program in Ghana, Kenya and Malawi. The next step is deciding how to fund the vaccine’s rollout over the coming years.

Mosquito drinks blood from a person
More than 260,000 African children under five die from malaria each year • Source: Alamy

GlaxoSmithKline’s malaria vaccine Mosquirix (RTS,S), which has just been cleared for wider distribution in Africa by the World Health Organization, is the latest product to be approved for use based on a scientific opinion from the European Medicines Agency under a special procedure for medicines destined for non-EU markets.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Approvals

More from Product Reviews